Abstract
Dengue fever, the most prevalent arbovirus disease, has a broad spectrum of clinical manifestations, ranging from asymptomatic to dengue hemorrhagic fever and dengue shock syndrome. Dengue fever has the potential to involve the nervous system. Acute transverse myelitis is a life-threatening complication of dengue fever, though rarely reported. We report a case of dengue fever-induced transverse myelitis in a 51-year-old male who presented with progressive paraplegia, sensory disturbance, and urinary retention preceded by a febrile illness, vomiting, and retro-orbital pain two weeks before. His serology was positive for immunoglobulin M (IgM) to dengue virus and non-structural protein (NS-1). Magnetic resonance imaging revealed hyperintense signals suggestive of acute transverse myelitis. After ruling out all other possible causes, a possible diagnosis of dengue fever-induced transverse myelitis was made. His condition improved gradually after starting methylprednisolone.
Keywords: dengue ns1, post dengue transverse myelitis, acute transverse myelitis (atm), complications of dengue fever, dengue virus infection
Introduction
Dengue fever, a viral illness transmitted by the Aedes mosquito, is prevalent in tropical and subtropical regions, notably in the American and Asian populations. Dengue fever has a broad spectrum of clinical manifestations and clinical syndromes ranging from sub-clinical infections to life-threatening infections such as dengue shock syndrome and dengue hemorrhagic fever [1]. Patients with dengue fever generally present with fever, nausea, vomiting, and abdominal and retro-orbital pain [2]. Dengue fever has the potential to involve the multi-organ system and has also been associated with cardiomyopathy, hepatic injury, depression, pneumonia, iritis, and orchitis. Neurological complications of dengue fever have also been reported [3]. Transverse myelitis is a life-threatening complication of dengue fever, though rarely reported, and only a limited number of cases have been published [4]. We report a case of acute transverse myelitis induced by dengue fever.
Case presentation
A 51-year-old male was brought to the emergency department with walking difficulty, sensory disturbance, and urinary retention. He first developed lower extremity weakness three days earlier, followed by sensory disturbance and urinary retention. These symptoms had gradual onset, progressive, with no aggravating and relieving factors. He also reported high-grade fever, myalgia, retro-orbital pain, and multiple episodes of vomiting two weeks ago. His blood picture showed decreased platelet count on serial complete blood counts, dengue serology was positive for nonstructural protein 1 (NS1), and he was diagnosed with dengue fever. He had no history of abdominal pain, sore throat, cough, ear discharge, skin rash, backache, or trauma.
On examination, he was hemodynamically stable and well-oriented to time, place, and person. On neurological examination, he had decreased motor strength in his lower extremities with a power of grade 1/5 on the left side and grade 0/5 on the left side, with normal strength in his upper extremities. He had hypoesthesia with absent reflexes in his lower limbs, and the sensory level was noted at the T-6 dermatome with impaired joint position sensation of the lower limbs. He had grade B paresis on the Frankel Grade.
Higher mental function and cranial nerve examinations were within normal limits. Cardiovascular and respiratory system examinations were unremarkable. He underwent brain magnetic resonance imaging (MRI), which was normal. Results of cerebrospinal fluid (CSF) analysis are shown in Table 1. Spine T-2 weighted MRI revealed hyperintense signals in the thoracic T2-T6 region, and nerve conduction study findings were suggestive of transverse myelitis (Figure 1).
Table 1. Results of the CSF analysis.
CSF: cerebrospinal fluid analysis, VDRL: venereal disease research laboratory
| CSF | Lab Values | Reference Range |
| Color | Colorless | Colorless |
| Opening pressure | 12 | 06-20 cmH2O |
| Proteins | 71 | 14-47 mg/dl |
| Glucose | 87 | 42-75 mg/dl |
| Red cell count | 11 | 0-1/mm3 |
| White cell count | 19 | 0-6/mm3 |
| VDRL | Nonreactive | Nonreactive |
| Gram stain | Negative | Negative |
| Bacterial antigen | Negative | Negative |
Figure 1. T-2 weighted spinal MRI demonstrating hyperintense signals from the T2-T6 vertebrae (A, B).
Repeated serology for dengue fever was positive for NS-1 and immunoglobulin (Ig) M and IgG. Further workup revealed normal blood cell count and serum biochemistry. His serology was negative for coronavirus disease 2019, syphilis, human immunodeficiency virus (HIV), herpes virus serology, viral hepatitis, and autoimmune workup (Table 2).
Table 2. Detailed workup to rule out other etiologies of transverse myelitis.
COVID-19: coronavirus disease 2019, HCV: hepatitis C virus, HIV: human immunodeficiency virus, VDRL: venereal disease research laboratory, PCR: polymerase chain reaction, HSV: herpes simplex virus
| Workup | Results |
| COVID-19 PCR | Negative |
| Hepatitis B surface antigen | Negative |
| Anti HCV antibody | Negative |
| Anti-nuclear antibody test | 1:40 |
| Rheumatoid factor | <5 IU/ml |
| HIV antigen | Negative |
| VDRL | Negative |
| HSV PCR | Negative |
He was diagnosed with acute transverse myelitis induced by dengue fever after ruling out all other possible etiologies. His condition improved gradually after starting high-dose intravenous methylprednisolone (1g/daily) for five days, followed by tapering oral steroids and physiotherapy. He was discharged 10 days later on tapering oral steroids. On his recent visit four weeks later, he was doing well, with improved symptoms.
Discussion
Dengue fever has the potential to involve the nervous system (Figure 2) [3]. Transverse myelitis is an uncommon, life-threatening, inflammatory neurological disorder characterized by rapid onset of weakness, sensory disturbance, and bladder or bowel dysfunction. It has a wide spectrum of etiologies such as para-infectious, post-vaccination, systemic autoimmune diseases, and vasculitis (Figure 3) [5,6]. Transverse myelitis induced by dengue fever is uncommon, and only a limited number of cases have been published. A systemic review of neurological manifestations of dengue fever revealed that the incidence of transverse myelitis is low, and out of 2672 cases, only 61 patients were diagnosed with transverse myelitis after dengue fever. Of those, 32 patients were male, and the mean age of presentation was 33.1 years, with an average time of 11.7 days from dengue to the first onset of neurological symptoms of transverse myelitis [4]. We have tabulated the reported cases of transverse myelitis complicated by dengue fever reported after 2018 (Table 3) [3,7-11].
Table 3. Reported cases of transverse myelitis induced by dengue fever.
M: male, F: female, IgM: Immunoglobulin M, IgG: Immunoglobulin G, T2-W: T2-weighted, T: thoracic. NS-1: non-structural protein-1
| Author et al. | Age (year)/sex | Dengue diagnosis | Days to neurological symptoms | Symptoms | Imaging | Management | Outcome |
| Chaudhry et al. [7] | 55/F | NS-1, IgM, IgG | 4 | Urinary retention, paraplegia, sensory loss | Hyperintense signals on T2-W at T9-T10 | Steroids, physiotherapy | Recovered |
| Farias et al. [8] | 53/M | IgM | 3 | Lower limb weakness, urinary retention | Hyperintense signals on T2 at the T4/5 level | High-dose steroids | Recovered |
| Malik et al. [3] | 15/M | NS-1 | 42 | Lumber pain, bowel, and bladder dysfunction | T2 hyperintense signals from T5 to conus medullaris | High-dose steroids, physiotherapy | Recovered |
| Landais et al. [9] | 24/F | NS-1, IgM, IgG | 7 | Paraparesis, urinary retention | T2 hyperintense lesions at the cervical and thoracic level | High-dose steroids | Sphincter disorder persisted |
| Lana-Piexoto et al. [10] | 41/M | IgM | 24 | Lower limb weakness, sensory impairment | T2 hyperintense signal intensity from T5 to the conus medullaris | High-dose steroids | Recovered |
| Tan et al. [11] | 61/F | NS-1 | 6 | Lower limb weakness, urinary retention | Hyperintensity signals on T2 at T9-T10 | High-dose steroids, physiotherapy | Recovered |
Figure 2. Neurological features of dengue fever.
Image credit: Saman Siddique, Hira Nasir
Figure 3. Etiology of transverse myelitis.
Image credit: Kiran Kumari, FNU Harsha
The pathophysiology of dengue fever-induced transverse myelitis is not yet defined. Possible mechanisms include the direct neurotropic effect of the virus on the nervous system or post-infectious complications [10,11]. A direct neurotropic effect has been reported in a few cases of myelitis, with the isolation of viral antigens in the CSF of the patients in an early phase of infection. Viral antigens can be found in the spinal cord, brain, and brainstem in humans, infecting the neural tissues [12]. Dengue virus has also been reported to replicate within CSF passing through the blood-brain barrier disrupted by intense inflammatory response. Transverse myelitis associated with post-infectious dengue virus involves a transient stimulated autoimmune response through molecular mimicry and non-specific activation of auto-reactivated T-cell clones, directing myelin or other nervous tissues and stimulating a cascade of inflammatory response [13]. Post-infectious myelitis typically manifests one or two weeks after the onset of initial dengue fever manifestations, whereas para-infectious dengue myelitis can occur within the first week of infection [12,13].
Spinal MRI is the modality of choice in diagnosing transverse myelitis, and the presence of T-2 weighted hyperintense signals is suggestive of myelitis [14]. Detecting dengue virus antigen in CSF serves as an indicator of acute phase infection caused by dengue virus. Notably, the window for detecting the virus in serum and CSF is brief; however, the test is highly efficacious during the viremia phase. Hence, molecular testing is preferred within the initial week following the symptoms, and beyond this period, serologic testing becomes the preferred diagnostic method for dengue infection [15]. Ruling out other viral causes is also recommended. Dengue fever is managed conservatively depending on the severity, as there is no recommended viral treatment. Dengue fever-induced transverse myelitis is managed with high-dose steroids [14,15]. Our patient was diagnosed with dengue-induced myelitis, and his condition improved after starting steroids.
Conclusions
Although rare, transverse myelitis is a life-threatening complication of dengue fever that clinicians should be aware of, particularly in endemic regions. Transverse myelitis has a favorable prognosis in case of early recognition and aggressive management with high-dose steroids. Our case highlights the need for careful observation in the monitoring of dengue patients for neurological complications, enabling timely management and improved outcomes.
The authors have declared that no competing interests exist.
Author Contributions
Concept and design: Hira Nasir, FNU Karishma, Saman Siddique, Kiran Kumari
Drafting of the manuscript: Hira Nasir, FNU Karishma, FNU Harsha, Saman Siddique, FNU Mainka
Supervision: Hira Nasir, FNU Karishma, FNU Harsha, Sindhu Rani, Saman Siddique, Kiran Kumari, FNU Mainka
Acquisition, analysis, or interpretation of data: FNU Karishma, FNU Harsha, Sindhu Rani, Kiran Kumari, FNU Mainka
Critical review of the manuscript for important intellectual content: Sindhu Rani, Kiran Kumari
Human Ethics
Consent was obtained or waived by all participants in this study
References
- 1.Dengue infection: global importance, immunopathology and management. Kularatne SA, Dalugama C. Clin Med (Lond) 2022;22:9–13. doi: 10.7861/clinmed.2021-0791. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Symptoms and treatment dengue. CDC. [ Jan; 2024 ]. 2024. https://www.cdc.gov/dengue/symptoms/index.html https://www.cdc.gov/dengue/symptoms/index.html
- 3.Longitudinally extensive transverse myelitis following dengue virus infection: a rare entity. Malik S, Saran S, Dubey A, Punj A. Ann Afr Med. 2018;17:86–89. doi: 10.4103/aam.aam_30_17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Risk of transverse myelitis following dengue infection: a systematic review of the literature. Badat N, Abdulhussein D, Oligbu P, Ojubolamo O, Oligbu G. Pharmacy (Basel) 2018;7:3. doi: 10.3390/pharmacy7010003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Transverse myelitis. [ Jan; 2024 ]. 2022. https://www.mayoclinic.org/diseases-conditions/transverse-myelitis/symptoms-causes/syc-20354726 https://www.mayoclinic.org/diseases-conditions/transverse-myelitis/symptoms-causes/syc-20354726
- 6.Transverse myelitis (TM) [ Jan; 2024 ]. 2022. https://my.clevelandclinic.org/health/diseases/8980-transverse-myelitis https://my.clevelandclinic.org/health/diseases/8980-transverse-myelitis
- 7.Association of dengue with longitudinally extensive transverse myelitis and subarachnoid hemorrhage: an unusual presentation. Chaudhry N, Aswani N, Khwaja GA, Rani P. Ann Indian Acad Neurol. 2018;21:158–160. doi: 10.4103/aian.AIAN_40_18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Encephalitis and transverse myelitis in dengue and chikungunya coinfection. Farias LA, Ferragut JM, Pires Neto RD. Rev Soc Bras Med Trop. 2018;51:403. doi: 10.1590/0037-8682-0259-2017. [DOI] [PubMed] [Google Scholar]
- 9.Acute myelitis associated with dengue infection. Landais A, Hartz B, Alhendi R, Lannuzel A. Med Mal Infect. 2019;49:270–274. doi: 10.1016/j.medmal.2018.10.003. [DOI] [PubMed] [Google Scholar]
- 10.Myelitis and cauda equina involvement following dengue fever. A case report and review of the literature. Lana-Peixoto MA, Pedrosa D, Talim N, Amaral JM, Lacerda PE, Kleinpaul R. Mult Scler Relat Disord. 2018;20:48–50. doi: 10.1016/j.msard.2017.12.013. [DOI] [PubMed] [Google Scholar]
- 11.Dengue-related longitudinally extensive transverse myelitis. Tan W, Lim CT. Neurol India. 2019;67:1116–1117. doi: 10.4103/0028-3886.266296. [DOI] [PubMed] [Google Scholar]
- 12.Preferential gray matter involvement in dengue myelitis. Kunishige M, Mitsui T, Tan BH, et al. Neurology. 2004;63:1980–1981. doi: 10.1212/01.wnl.0000144194.29643.d0. [DOI] [PubMed] [Google Scholar]
- 13.The pathogenesis of spinal cord involvement in dengue virus infection. An J, Zhou DS, Kawasaki K, Yasui K. Virchows Arch. 2003;442:472–481. doi: 10.1007/s00428-003-0785-3. [DOI] [PubMed] [Google Scholar]
- 14.Transverse Myelitis: pathogenesis, diagnosis and treatment. Krishnan C, Kaplin AI, Deshpande DM, Pardo CA, Kerr DA. Front Biosci. 2004;9:1483–1499. doi: 10.2741/1351. [DOI] [PubMed] [Google Scholar]
- 15.Transverse myelitis. Beh SC, Greenberg BM, Frohman T, Frohman EM. Neurol Clin. 2013;31:79–138. doi: 10.1016/j.ncl.2012.09.008. [DOI] [PMC free article] [PubMed] [Google Scholar]



